1.
Susanti LR, Mustika A, Rahmawati LD, Wungu CDK. Efficacy and Safety of Ozoralizumab versus Moxibustion for Rheumatoid Arthritis. FMI [Internet]. 2024 Dec. 11 [cited 2024 Dec. 13];60(4):358-71. Available from: https://e-journal.unair.ac.id/FMI/article/view/64949